Kevin Dinneen

More than 53,000 peer-reviewed studies now exist on cannabis, yet NHS prescriptions remain severely limited as UK regulators say there isn’t sufficient evidence to prescribe it more widely on the NHS.

Cannabis-based medicines improved pain, sleep, anxiety and quality of life in 497 fibromyalgia patients over 18 months, according to new data from the UK Medical Cannabis Registry.

A single dose of psilocybin combined with therapy helped 41% of participants quit smoking for six months, compared to just 10% using nicotine patches, according to a new study from Johns Hopkins University.

The black market has shrunk, police investigations are restricted, youth use remains stable, and the medical cannabis industry has become Europe's largest, according to the second evaluation of Germany’s partial cannabis legalisation.

Research conducted by vaporiser manufacturer PAX suggests dry herb vaping dramatically reduces exposure to toxic compounds found in cannabis smoke.

Archaeologists used a new technique to discover that cannabis was integral to daily life in northern China during the late Neolithic period, challenging previous understanding of the plant's ancient role

Research tracking 810 Danish children found no evidence that prenatal cannabis exposure harmed cognitive or language development by age three, contrary to researchers' initial hypothesis.

Removing cost barriers to medical cannabis enabled patients with chronic pain to significantly reduce their reliance on prescription opioids, with nearly a quarter stopping opioid use entirely, according to new research.

Almost 90% of participants in a Canadian survey regard cannabis as an effective and safe pain management option, with one in six having used it in the past month to treat severe joint pain.

Dispelling the 'lazy stoner' stereotype, the study found that people who used cannabis were shown to be more likely to engage in light and medium exercise.